Workflow
IRadimed (IRMD) Beats Q3 Earnings and Revenue Estimates
IRMDiRadimed(IRMD) ZACKS·2024-10-31 14:26

分组1 - iRadimed reported quarterly earnings of 0.43pershare,exceedingtheZacksConsensusEstimateof0.43 per share, exceeding the Zacks Consensus Estimate of 0.39 per share, with an earnings surprise of 10.26% [1] - The company achieved revenues of 18.33millionforthequarterendedSeptember2024,surpassingtheZacksConsensusEstimateby0.7218.33 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.72%, and showing an increase from 16.51 million year-over-year [2] - iRadimed has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] 分组2 - The stock has gained approximately 11.5% since the beginning of the year, while the S&P 500 has increased by 21.9%, suggesting underperformance relative to the broader market [3] - The current consensus EPS estimate for the upcoming quarter is 0.43onrevenuesof0.43 on revenues of 20.02 million, and for the current fiscal year, it is 1.61onrevenuesof1.61 on revenues of 73.74 million [7] - The Medical - Instruments industry, to which iRadimed belongs, is currently ranked in the top 24% of over 250 Zacks industries, indicating a favorable industry outlook [8]